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Guidelines and Guidance
R
ecent commentaries advocate routinely offering study 
results to research participants [1,2]. However, debate 
continues over the scope and limits of investigators’ 
responsibilities in this regard. A 2006 review identiﬁ  ed 30 
national and international policies and guidelines concerning 
the duty to return research results [3], of which 21 were 
published in the last decade. Worldwide interest in this 
complex issue will likely continue to rise in light of the 
increasing relevance of the results of biomedical research to 
participants’ health and well-being.
Unfortunately, many policies and commentaries on 
communication of results either do not adequately take into 
account relevant available data, or fail to recognize the lack 
thereof. For example, existing data on participant desire and 
investigator support for communication of research results 
have not been synthesized, nor have the data on potential 
positive and negative consequences that communication of 
results may have for both participants and researchers. 
The results of clinical research may be classiﬁ  ed as either 
aggregate study results, representing synthesized data and 
conclusions drawn from groups of research participants, or 
individual results, representing distinct items of data collected 
from or about individual participants. In this article, we 
present a narrative review of available data on the effects of 
communicating aggregate and individual research results 
on participants, investigators, and the research enterprise. 
We also present available data on disclosure practices 
and the attitudes of investigators and participants towards 
communication of research results. Our aim is not to provide 
deﬁ  nitive analyses of any of these domains; rather, it is to 
highlight trends in the literature as well as areas that require 
further investigation. 
Data on Communicating Research Results
A literature search revealed 28 empirical studies concerning 
communication of research results (Text S1). Because these 
studies encompass many different participant populations 
and research settings, we did not pool quantitative data or 
conduct a formal quality assessment of studies. Of the 28 
studies summarized below, 22 are primarily quantitative and 
six are primarily qualitative [4–9]. Sample size ranged from 
13 [7] to 8,941 [8]. Twelve studies involved either cancer 
research or the attitudes of patients with cancer [7,10–20]; 
seven studies involved genetics research [7,9,11,20–23]. 
Ten studies were conducted in the United States [9,10,16–
21,24,25], nine in the United Kingdom [4–8,11,26–28], 
four in Canada [14,15,29,30], one in France [23], and one 
in Sweden [22]. Three studies enrolled a multinational 
participant population [12,13,31]. 
Participant attitudes towards disclosure. Eighteen studies 
provided empirical data on participants’ desire to receive 
study results [5–11,14–16,18–23,27,32]. Nine studies involved 
aggregate study results, eight involved individual results, and 
one involved both (Table 1). Of studies that reported desire 
to receive results as a percentage of respondents, a median 
of 90% (range 20%–100%) wished to receive study results. 
In studies not reporting percentages, mothers of pediatric 
patients with cancer rated the importance of aggregate 
study results at a mean of 4.5 of a maximum importance 
of 5 [10], parents of infants in a randomized controlled 
trial of extracorporeal membrane oxygenation (ECMO) 
“felt strongly they should be sent the trial results” [5], and 
relatives of deceased patients with prostate cancer stated that 
they “had a right to know information that they could use to 
make personal risk management decisions” [7]. When asked 
an open-ended question about their experience in a study 
allowing them to access their individual obstetric records, 
99 of 247 pregnant women volunteered a desire to receive 
aggregate study results without being prompted [6].
Nine studies assessed participants’ reasons for wanting 
aggregate or individual study results. Participants in these 
studies cited clinical signiﬁ  cance (e.g., treatment, prevention, 
or understanding of a disease) for self or relatives [7–11,23], 
respect for participants in research or a “right” to receive 
results [5,11,14], and raising public awareness of research 
[14]. Interestingly, Wendler et al. reported that the mere 
The Guidelines and Guidance section contains advice on conducting and reporting 
medical research.
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fact that investigators have information about participants 
that participants lack contributes to the desire to receive 
individual research results [20]. In a study by Fernandez et al., 
participants suggested that the possibility of causing distress 
to families of deceased participants or situations in which 
participants were harmed or not helped by the research could 
be reasons for not disclosing research results [14]. However, 
Partridge et al. reported that participants wanted to be 
contacted with aggregate results even if they were not helped 
by the research [16].
Ten studies [5,8–11,14–16,18,19] assessed participants’ 
preferences for the method of receiving research results. Two 
prospective studies of adolescent patients with cancer and 
parents of children with cancer by Fernandez et al. report 
that (1) 60% of participants felt communication of results by 
mail would be satisfactory, though 50% stated that they would 
prefer face-to-face contact [15]; and (2) approximately 75% 
of participants would prefer to receive results with positive or 
neutral implications by letter or e-mail, while approximately 
53% of participants would prefer to have results with negative 
Table 1. Participant Desire for Study Results
Study Year Typea N Population Comment
Elbourne [6] 1987 A 247 Pregnant women allowed access to their 
obstetric records
99 of 247 women mentioned looking forward to 
receiving study results in response to an open-ended 
question about their feelings regarding enrollment.
Bunin et al. [10] 1996 A 109 Mothers of pediatric patients with brain 
tumors
Mothers of patients rated the importance of study 
results as 4.5/5 on Likert scale.
Snowdon et al. [5] 1998 A 24 Parents of infants in a clinical trial of ECMO Qualitative description that parents of infants in trial 
“felt strongly they should be sent the trial results.”
Partridge et al. [16] 2003 A 51 Women in a breast cancer treatment trial 96% of respondents wanted to be informed of trial 
results.
Schulz et al. [19] 2003 A 382 Retinoblastoma survivors and parents of 
affected children
1.4% of respondents would have preferred not to 
receive results regarding their risk of developing future 
cancers.
Fernandez et al. [15] 2005 A 20 Adolescents with cancer and parents of 
children with cancer
90% of participants wished to receive the results of 
research in which they participated.
Partridge et al. [18] 2005 A 94 Women in a treatment trial for ductal 
carcinoma in situ
90% of participants elected to receive results related to 
the early closure of the trial. 
Dixon-Woods et al. [8] 2006 A 8,941 Women in a randomized controlled trial of 
antibiotics during pregnancy
20% of participants requested trial results. Many 
of those requesting aggregate results also wanted 
information regarding their treatment allocation.
Fernandez et al. [14] 2007 A 40 Adolescents with cancer and parents of 
children with cancer
100% of 30 parents and 10 adolescents would want to 
receive study results regardless of implication. >95% 
felt they had “strong” or “very strong” rights to receive 
study results.
Wendler et al. [32] 2002 I 504 Research participants and Medicare 
recipients questioned about research with 
stored samples
88.8% of respondents would want to receive study 
results of uncertain clinical signiﬁ  cance.
Richards et al. [11] 2003 I 1,484 Women participants in an epidemiological 
study of breast cancer genetics
93% of participants indicated a desire to be informed if a 
BRCA1 or BRCA2 mutation was found.
Fong et al. [21] 2004 I 429 Adult Hawaiians questioned about research 
with stored samples
90.7% of respondents would want individual research 
results disclosed to them. 82.1% would want their 
physicians to be notiﬁ  ed of results.
Hoeyer et al. [22] 2004 I 589 Randomly selected residents of a Swedish 
county
83.4% of respondents would want to receive research 
results containing information about genetic 
predisposition to disease. However, 66% of these would 
only want results if there was treatment or prevention 
available.
Ormond et al. [9] 2004 I 808 Participants in a genetics database 96% of participants wanted to be recontacted if 
“medically signiﬁ  cant” ﬁ  ndings came out of their 
participation.
Dinnett et al. [27] 2006 I 2,067 Participants in a cardiovascular disease 
prevention trial
67% of participants wanted to be unblinded to their 
treatment allocation and receive their on-trial lipid 
proﬁ  les.
Ormondroyd et al. [7] 2007 I 13 Relatives of deceased male participants with 
BRCA2 mutations
Qualitative description that 13 members of 3 families 
(100% of participants surveyed) believed that clinically 
signiﬁ  cant results should be communicated to relatives 
of a deceased participant.
Wendler et al. [20] 2007 I 561 Patients with cancer and participants in 
Alzheimer disease research
78% of participants and 90% of patients would want to 
know individual results of predictive Alzheimer disease 
testing if the investigator knew results.
Moutel et al. [23] 2005 B 125 Patients with HIV in a pharmacogenomics 
study
71% of respondents wanted aggregate study results; 
76% wanted individual results.
aType of research results targeted by the named study: A = aggregate study results, I = individual results, B = both.
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implications communicated in person [14]. Participants in 
a longitudinal genetic database were “relatively open with 
regards to how they would prefer to be recontacted” with 
individual results [9], and participants in a clinical treatment 
trial for breast cancer preferred that their physicians 
communicate the aggregate results of clinical trials in which 
they participated [16].
Participants were asked to retrospectively evaluate 
written communication of research results in ﬁ  ve studies 
[5,8,10,18,19]. Mothers of child participants in an 
epidemiological study of brain tumors found written 
aggregate study results understandable and important; 
however, 40% wanted a phone number to call with questions 
[10]. Written notiﬁ  cation of aggregate study results 
with contact numbers was also the preferred method of 
communication for retinoblastoma survivors and participants 
in a trial of antibiotics during pregnancy [8,19]. In addition, 
74% of women informed by mail of the early stoppage of 
a phase II trial of breast excision for ductal carcinoma in 
situ felt comfortable with this method of notiﬁ  cation [18]. 
However, parents of infants who had taken part in a clinical 
trial of ECMO reported mixed experiences with receiving 
written communication about aggregate study results, as 
many felt the information was either too complex or too 
simplistic [5]. 
Investigator attitudes and practices regarding disclosure. 
Five studies assessed investigators’ support for communicating 
research results to participants [4,12,17,26,31]. Four studies 
involved aggregate study results and one involved individual 
results (Table 2). A substantial majority of investigators 
surveyed in four studies supported communicating study 
results to participants [12,17,26,31]. In the remaining study, 
only one-third of six midwives and ten physicians surveyed 
favored the communication of clinical trial results regarding 
fetal heart monitoring techniques [4].
Cancer investigators identiﬁ  ed the cost and time involved 
in preparing a lay summary as well as difﬁ  culty in contacting 
participants as major barriers to communicating aggregate 
study results [12]. Clinical investigators also identiﬁ  ed 
possible biasing of study follow-ups and cost as major barriers 
to communicating individual results [26]. In both cases, a 
minority of investigators identiﬁ  ed negative psychological 
consequences as a perceived barrier to communication of 
research results [12,26]. Cancer clinicians in another study 
expressed a reluctance to inform participants of negative 
study conclusions owing to a desire to protect participants 
from harmful psychological consequences [17]. 
The chairs of Canadian research ethics boards (REBs) 
overwhelmingly supported offering research results after the 
conclusion of the study [30], and the monitoring committee 
of a pharmacogenetics study involving HIV-infected patients 
strongly favored communicating results of “direct beneﬁ  t” 
to the participant, but expressed doubts regarding the 
communication of other results [23].
Six studies assessed the practices and policies of 
investigators and institutions concerning the communication 
of research results to participants [12,13,17,26,29,31]. 
Four studies involved aggregate study results, one study 
involved individual results, and one involved both (Table 
3). Communicating research results seems to represent 
the exception to practice. For example, only ﬁ  ve of 150 
institutions surveyed by Fernandez et al. had a formal 
mechanism for returning research results to participants [12], 
and only 3% of 180 consent forms for leukemia clinical trials 
indicated that participants could receive study results [13]. 
Furthermore, only nine of 22 Canadian REBs surveyed had 
policies addressing communication of results or required 
investigators to address the issue themselves [29].
Impact of disclosure on participants. Eight studies 
empirically assessed the impact of receiving study results, all 
Table 2. Investigators’ Support for Communicating Research Results
Study Year Typea N Population Comment
Garcia [4] 1987 A 16 Doctors and midwives involved in a 
randomized controlled trial of fetal heart 
monitoring
One-third of those interviewed felt that results of the study 
should be shared with mothers who had participated. 
Fernandez et al. [12] 2003 A 150 Primary investigators in the Children’s 
Oncology Group
69.3% of investigators supported or strongly supported 
the development of a guideline mandating provision 
of research results to participants. Investigators felt 
major barriers to implementation were preparation 
of lay summary of results (70%) and time involved in 
communication of results (62%).
Partridge et al. [17] 2004 A 796 Oncology physicians and nurses 78.9% believed trial results should be offered in most 
cases. 79.6% would be willing to offer trial results. 83% 
believed that trial results should be communicated by 
participants’ physicians. 16.2% of respondents “believed 
an obligation to offer results…would make them less likely 
to enroll patients on studies.”
Rigby et al. [31] 2005 A 158 Investigators presenting oral abstracts at 
American Society of Hematology Annual 
Meeting
69% of investigators supported or strongly supported the 
concept of return of research results.
MacNeil et al. [30] 2007 A 77 Canadian REB chairs 94.8% of REB chairs supported offering research results to 
participants after a study’s completion.
Di Blasi et al. [26] 2002 I 139 Investigators who conducted placebo-
controlled trials
75% of investigators who did not inform participants 
of their treatment allocation (40/53) would consider 
informing them in the future.
aType of research results targeted by the named study: A = aggregate study results, I = individual results.
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of which involved aggregate results [5,7,8,10,11,18,19,24] 
(Table 4). These studies used various methods of assessing 
participants’ reactions to receiving study information, 
including interviews [5,7,8,11], Likert scales of possible 
psychological reactions [10,19], the revised Impact of Event 
Scale [18], and the McMaster Health Index Questionnaire 
[24]. All but one study [24] reported some incidence of 
negative psychological consequences for participants, 
including increased anxiety, anger, guilt, or upset. However, 
six studies [5,7,8,10,19,24] reported psychological beneﬁ  ts 
for participants from receiving research results, including 
pleasure, satisfaction, and relief. 
Importantly, the vast majority of participants reported 
feeling that it was important to receive study results, despite 
potentially negative emotional impact (Table 1). For 
example, Schulz et al. [19] reported that approximately a 
quarter of retinoblastoma survivors or parents of children 
with retinoblastoma indicated that receiving aggregate study 
results regarding their risk of developing second malignancies 
made them “very” to “extremely” frightened, anxious, or 
sad. However, 20% of participants were “very” to “extremely” 
relieved by the results, and only 1.4% of participants in this 
study would have preferred not to receive results. 
Three studies examined correlations between education 
and psychological impact of disclosure: one found that 
participants with less than a college education were 
signiﬁ  cantly more sad, angry, overwhelmed, or frightened 
than those with a college education [19], one found the 
opposite [18], and one found no correlation between 
educational level and psychological impact of disclosure [10]. 
Only the study by Schulz et al. addressed clinical follow-up 
after receiving research data [19]. The study authors found 
that despite their recommendations, only 18% of participants 
spoke with their physicians about the disclosed results, 16% 
of survivors attended cancer screening check-ups, and 12% of 
parents of child retinoblastoma survivors took their children 
to be screened. The authors hypothesized that the impersonal 
nature of written communication may have led to poor 
utilization of clinically signiﬁ  cant information. 
Impact of disclosure on investigators. One study addressed 
the costs of communicating research results. Dinnett et 
al. reported that expenses associated with communicating 
treatment allocation and lipid proﬁ  les to participants 
included preparation, printing, and distribution of letters as 
well as additional salary support for existing staff. The authors 
also report receiving only 21 phone calls after unblinding 
1,391 participants [28]. 
Impact of disclosure on the research enterprise. Buchwald 
et al. show trends (p-values between 0.09 and 0.13) indicating 
that after communication of aggregate study results, 726 
participants were more likely to be (1) satisﬁ  ed with their 
decision to enroll, (2) satisﬁ  ed with randomization allocation, 
and (3) disposed to advise others to join a research study 
after communication of aggregate study results [24]. 
Snowdon et al. report that of 31 parents notiﬁ  ed of their 
infant’s allocation to the ECMO or standard care groups 
in a completed clinical trial, few said that this information 
affected their view of the trial, randomization, or their doctor 
[5].
Discussion
As we have conducted a narrative review of studies 
concerning communicating research results to participants, 
rather than a systematic review, deﬁ  nitive conclusions 
about ﬁ  ndings and their ethical import cannot be drawn. 
Nevertheless, the data reviewed here suggest several 
important implications. Available data consistently indicate 
that research participants want aggregate and clinically 
signiﬁ  cant individual study results made available to them. 
Participants’ desires do not necessarily determine policy, but 
respect for participants requires taking their preferences 
seriously. Though investigators appear to support the 
communication of aggregate study results, less is known about 
investigators’ attitudes towards communicating individual 
Table 3. Research Results Communication Practices
Study Year Typea N Population Comment
Fernandez et al. [13] 2003 A 181 Consent forms for leukemia studies from 
different institutions
2.8% of informed consent documents indicated that 
participants had a right to receive study results.
Fernandez et al. [12] 2003 A 150 Principal investigators in the Children’s 
Oncology Group
5 institutions (3.3%) had a formal mechanism to return 
aggregate results to research participants. Only one of 
these provided a written lay summary to participants.
Partridge et al. [17] 2004 A 796 Oncology physicians and nurses 62.4% of respondents reported offering results to patients 
less than one-ﬁ  fth of the time.
MacNeil et al. [29] 2006 A 22 Canadian university-based REBs 9 REBs addressed the disclosure of research results 
themselves (2) or required investigators to do so in their 
research applications (7).
Di Blasi et al. [26] 2002 I 139 Investigators conducting placebo-
controlled trials
45% of investigators informed all or most participants 
of their treatment arm allocation. 5% informed those 
who requested to know, and 50% did not inform. Most 
participants were informed in person (48%) or by mail 
(25%).
Rigby et al. [31] 2005 B 158 Investigators presenting oral abstracts at 
American Society of Hematology Annual 
Meeting
30% of investigators indicated that they had a formal 
plan for the offer of research results to participants; 40% 
of these returned aggregate and individual results. 7% 
reported that their institutional review board or REB 
required the offer of research results. 23% did not know 
whether such a policy existed.
aType of research results targeted by the named study: A = aggregate study results, I = individual results, B = both.
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research results or about the costs and time required to do 
so. Future research should focus on these issues, including 
ways to facilitate communication of results by addressing 
investigators’ concerns.
It may be helpful to consider the signiﬁ  cant body of 
literature from the 1990s concerning worker notiﬁ  cation of 
research showing increased occupational health risk [10]. 
Employers initially resisted notifying workers of risk, citing 
concerns of causing unduly negative psychological reactions 
as well as affecting workers’ insurability, employability, and 
credit rating [33–36]. Subsequent research showed little 
evidence that notiﬁ  cation of occupational health risks leads 
to signiﬁ  cant long- or short-term psychological consequences 
[37–39]. One study also reported that after 3,189 notiﬁ  cation 
letters were mailed containing a toll-free number for 
additional information, only 40 calls were received, suggesting 
that cost of follow-up after communication of results may not 
be especially burdensome [40]. Authors in the occupational 
health literature have carefully assessed the method, 
timing, and content of risk-notiﬁ  cation procedures; clinical 
investigators considering how to approach communication 
of research results may ﬁ  nd these analyses and the lessons 
learned useful [34,40–46].
Both the clinical research and occupational health 
literature demonstrate that some participants will show 
positive and/or negative psychological changes after receiving 
research results. However, studies of the psychological impact 
of genetic testing demonstrate that individuals tend to 
exhibit less emotional distress than anticipated by clinicians, 
and show strong coping skills in dealing with undesired 
results [47–50]. Likewise, the balance of evidence suggests 
that false reassurance is not a signiﬁ  cant problem for the 
communication of research results [51–55]. Three studies 
that identify false reassurance suggest that inadequacies in 
explaining results may be to blame, and recommend that, in 
the case of genetic testing, the implications of positive and 
negative results be emphasized equally [56–58]. The impact 
of communicated study results may also vary by study type 
and characteristics of the participant population, including 
diagnoses, health status, education, and health literacy. 
Investigators should therefore tailor their communication 
practices with respect to the situation and needs of their 
intended audience. Future research should assess the effect 
of various modes of communicating research results on 
psychological sequelae, health behaviors, and understanding 
of results by participants. Importantly, despite the potential 
for negative psychological consequences, participants want 
the opportunity to receive research results. These data 
suggest that fear of psychological harm should not be used as 
a reason not to offer research results, without clear evidence 
of a threat to participants’ safety. 
The costs of communicating research results to a study 
population remain unknown. However, in the absence of 
data, two points should be considered. First, concerns over 
cost of disclosure often stem from the assumption that 
research results must be communicated in person, and in 
the case of genetics research, by trained genetic counselors. 
Though in some cases, in-person disclosure may encourage 
follow-through on clinical recommendations and discourage 
false reassurance, participants often prefer to receive results 
Table 4. Impact on Participants of Receiving Research Results
Study Year Typea N Population Comment
Buchwald et al. [24] 1993 A 368 Patients assigned to partial ileal bypass 
surgery for hyperlipidemia
Patients’ perceptions of their emotional quality of life 
improved after disclosure of study results relative to a 
control group.
Bunin et al. [10] 1996 A 109 Mothers of pediatric patients with brain 
tumors
Patient mothers reported feeling moderate levels of guilt 
and anger. Patient mothers who felt the results applied to 
them felt also felt moderate levels of satisfaction and relief.
Snowdon et al. [5] 1998 A 24 Parents of infants in a clinical trial of 
ECMO
Even when results were emotionally exacting, the 
information removed uncertainty, provided an endpoint 
to difﬁ  cult events, promoted discussion within couples, 
and acknowledged their contribution to answering an 
important clinical question.
Richards et al. [11] 2003 A 21 Patients with breast cancer tested for 
BRCA-1 or BRCA-2 mutations
Several women were “shocked” to learn of their risk of a 
second breast cancer or ovarian cancer.
Schulz et al. [19] 2003 A 382 Survivors of, and parents of survivors 
of retinoblastoma participating in 
epidemiological research
Approximately 25% of respondents indicated that 
receiving aggregate study results regarding their risk of 
developing second malignancies made them “very” to 
“extremely” frightened, anxious, or sad. However, 20% 
were “very” to “extremely” relieved after receiving results.
Partridge et al. [18] 2005 A 94 Participants receiving notice of the early 
closure of a treatment study for ductal 
carcinoma in situ
Receiving results was associated with greater anxiety than 
not receiving results; however, anxiety levels were mild 
overall. 
Dixon-Woods et al. [8] 2006 A 20 Women in a randomized controlled trial 
of antibiotics during pregnancy
Half of participants expressed feelings of pleasure on 
receiving study results. For some women, the results 
revived memories of a difﬁ  cult time.
Ormondroyd et al. [7] 2007 A 13 Relatives of deceased male participants 
with BRCA2 mutations
Some participants expressed anxiety upon learning of 
their relative’s mutation. Genetic counseling helped 
alleviate this anxiety. Some participants were pleased to 
be recontacted. 
aType of research results targeted by the named study: A = aggregate study results.
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in writing with contact information. Second, although there 
will undoubtedly be some expenditure associated with 
communicating research results, cost should not be used 
as an argument against routine offering of study results to 
participants unless communicating results would substantially 
compromise the feasibility of the research. Future 
research should therefore assess the actual cost of various 
communication strategies.
It remains unclear whether communicating research results 
to participants will signiﬁ  cantly affect participants’ perception 
of investigators and biomedical research, or inﬂ  uence their 
likelihood of enrolling in future studies. More empirical data 
will be needed to resolve this issue; however, participants 
tend to be grateful when they receive study results, suggesting 
that such communication may bolster public opinion of 
investigators and the research they conduct.
Our analysis of the empirical literature on disclosure of 
research results to participants also revealed that the impact 
of presenting aggregate results to participants may equal that 
of presenting individual results. For example, while post-trial 
disclosure of treatment randomization or communication of 
individual genotypes may be clear examples of information 
relevant to individual participants, aggregate results of 
epidemiological studies may be just as individually relevant 
if participants know their own risk factors. Furthermore, 
many studies we found did not explicitly identify a focus 
on aggregate study results, individual results, or both. As 
communicating these two types of results may pose different 
practical and ethical challenges, researchers should specify 
the type(s) of results under consideration. 
The literature on communication of research results 
is limited by a lack of commonly used and well-validated 
measures for most outcomes of interest. This limitation may 
be especially problematic given that framing effects can 
result in widely differing estimates of preferences, attitudes, 
and impact. Additionally, detailed data extraction is often 
impossible when the impact of disclosure on participants is 
reported either qualitatively or using a Likert scale. It will 
therefore be necessary to employ rigorous study designs (e.g., 
controlled trials and longitudinal studies) to assess the effects 
of communicating research results. Finally, 16 of the 28 studies 
we identiﬁ  ed involved either cancer or genetics research. 
Future research should consider issues speciﬁ  c to other 
clinical research settings as well as to sociobehavioral research. 
As discussion and research move forward, we recommend 
that investigators include their planned approach to 
communicating aggregate and individual results in study 
protocols and address disclosure in informed consent 
documents. Research ethics committees should review the 
appropriateness of investigators’ plans for communicating 
results. Much still rests, however, on careful examination 
of the ethical issues involved in determining investigators’ 
responsibilities for communicating research results to 
participants. Policies should incorporate available empirical 
data into an ethical framework that (1) respects and 
supports the collaborative relationship between investigators 
and research participants and (2) enhances trust in, and 
trustworthiness of, research and researchers.  
Supporting Information
Text S1. Search Methodology
Found at doi:10.1371/journal.pmed.0050091.sd001 (80 KB DOC).
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